B. Norris

2.9k citations

25 papers · 2.2k indexed · h-index 15

Impact in

Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research

Papers in

Cancer Research 13
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 3
Oncology 18
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 8

Co-authors: Karen A. Gelmon Stephen Chia Caroline Speers Ivo A. Olivotto Chris Bajdik Ted Vandenberg Kathleen I. Pritchard Peter M. Ravdin
Journals: Journal of Clinical Oncology (14 papers)Annals of Oncology (4 papers)Cancer (2 papers)Cancer Biology & Therapy (1 paper)Clinical Breast Cancer (1 paper)
Partner nations: Canada United States United Kingdom

In The Last Decade

B. Norris

25 papers receiving 2.1k citations

Peers

Countries citing papers authored by B. Norris

Since Specialization

Citations

This map shows the geographic impact of B. Norris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Norris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Norris more than expected).

Fields of papers citing papers by B. Norris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Norris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Norris. The network helps show where B. Norris may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Norris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Norris Line = papers co-authored together B. Norris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 Journal of Clinical Oncology ·Kathleen I. Pritchard, Lois E. Shepherd, Judith‐Anne W. Chapman, B. Norris, Jacques Cantin, Paul E. Goss, Susan Dent, David Walde, Ted Vandenberg, B. Findlay, Susan E. O’Reilly, Carolyn F. Wilson, Lei Han, Ettie Piura, Timothy J. Whelan, Michaël Pollak	2011	66
2	A Phase II Trial of a Neoadjuvant Platinum Regimen for Locally Advanced Breast Cancer: Pathologic Response, Long-Term Follow-up, and Correlation With Biomarkers Clinical Breast Cancer ·Rinat Yerushalmi, Malcolm Hayes, Karen A. Gelmon, Stephen Chia, Chris Bajdik, B. Norris, Caroline Speers, Hyeong-Kook Kim, Susan E. O’Reilly, Sharon J. Allan, T. Çiğdem Oğuzoğlu	2009	15
3	Risk of early recurrence among postmenopausal women with estrogen receptor‐positive early breast cancer treated with adjuvant tamoxifen Cancer ·Hagen Kennecke, Heather L. McArthur, Ivo A. Olivotto, Caroline Speers, Chris Bajdik, Stephen Chia, Susan Ellard, B. Norris, Malcolm Hayes, Jeff Barnett, Karen A. Gelmon	2008	34
4	New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up Breast Cancer Research and Treatment ·Kristin C. Jensen, Dmitry Turbin, Samuel Leung, Melinda A. Miller, KATE JOHNSON, B. Norris, Trevor Hastie, Steven McKinney, Torsten O. Nielsen, David G. Huntsman, C. Blake Gilks, Robert B. West	2008	26
5	Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers Journal of Clinical Oncology ·Stephen Chia, B. Norris, Caroline Speers, Maggie C.U. Cheang, C. Blake Gilks, Allen M. Gown, David G. Huntsman, Ivo A. Olivotto, Torsten O. Nielsen, Karen A. Gelmon	2008	230
6	A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes Annals of Oncology ·B. Findlay, Katia Tonkin, Michael Crump, B. Norris, Maureen Trudeau, Martin E. Blackstein, Margot J. Burnell, Jamey Skillings, David M. J. S. Bowman, David Walde, Michelle S. Levine, Kathleen I. Pritchard, Michael Palmer, Dongsheng Tu, L. E. Shepherd	2007	8
7	Trastuzumab-Associated Peripheral Vascular Toxicity Journal of Clinical Oncology ·Kopcke, Mahāwitthayālai Sinlapākǭn. Khana Čhittrakam, B. Norris, Karen A. Gelmon	2007	4
8	A randomized phase II study of two different schedules of RAD001C in patients with recurrent/metastatic breast cancer Journal of Clinical Oncology ·Susan Ellard, Karen A. Gelmon, Chanidaphar Sanguanpuak, EA Baute Trujillo, Pallavi Deolal, B. Norris, L. McIntosh, Lesley Seymour	2007	12
9	Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen Annals of Oncology ·Hagen F. Kennecke, Ivo A. Olivotto, Caroline Speers, B. Norris, Stephen Chia, C. Bryce, Karen A. Gelmon	2006	78
10	Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer Journal of Clinical Oncology ·Ivo A. Olivotto, Chris Bajdik, Peter M. Ravdin, Caroline Speers, Andrew J. Coldman, B. Norris, Greg Davis, Stephen Chia, Karen A. Gelmon	2005	418
11	An independent population-based validation of the adjuvant decision-aid for stage I-II breast cancer Journal of Clinical Oncology ·Ivo A. Olivotto, Chris Bajdik, Peter M. Ravdin, B. Norris, A J Coldman, Victoria Angela Marchesini, Chanidaphar Sanguanpuak, Karen Gelmon	2004	3
12	A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129 Annals of Oncology ·Karen A. Gelmon, Ted Vandenberg, Lawrence Panasci, B. Norris, Michael Crump, Maria Eduarda Bueno Tallevi, William R. Walsh, Núria Silvestre Benach, Lesley Seymour	2003	11
13	Phase I Study of Prolonged Infusion Bryostatin-1 in Patients Cancer Biology & Therapy ·John L. Marshall, Orlance, Dorraya El‐Ashry, Удоратина О.В, Michael D. Johnson, B. Norris, Michael D. Oberst, Elizabeth Ness, Slawomir Wojtowicz‐Praga, Pankaj Bhargava, Naiyer A. Rizvi, Said Baidas, Michael Hawkins	2002	24
14	Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8 Journal of Clinical Oncology ·B. Norris, Kathleen I. Pritchard, K. James, James D. Myles, Katherine Bennett, van Rpg Roland Deelen, Jamey Skillings, B. Findlay, Ted Vandenberg, Paul E. Goss, Jean Latreille, Leona Rudinskas, W. Lofters, Maureen Trudeau, David Osoba, Vinayak Wadhwa	2000	118
15	Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology ·Mark N. Levine, V. Bramwell, Kathleen I. Pritchard, B. Norris, Lois E. Shepherd, Hakam Abu-Zahra, B. Findlay, David Warr, David M. J. S. Bowman, James D. Myles, Andrew Arnold, Ted Vandenberg, Robert G. MacKenzie, J Robert, J. Ottaway, Margot J. Burnell, Christopher Kwesi O. Williams, فریده جزء کبیری	1998	442
16	Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study. Journal of Clinical Oncology ·D Perrault, E. Eisenhauer, K. I. Pritchard, T. Lank, B. Norris, 林良一, Beth Fisher	1996	81
17	Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group. Journal of Clinical Oncology ·DavidJ. Pearson, Elizabeth A. Eisenhauer, Jacob A. Edwards, F Letendre, W. Lofters, B. Norris, Theodore A. Vandenberg, F. Delorme, A. Muldal	1996	137
18	Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. Journal of Clinical Oncology ·Theodore A. Vandenberg, K. Pritchard, E. Eisenhauer, Oscar Rydsjö, B. Norris, (unknown), 秀雄大庭, Robert Buckman, A. Muldal	1993	26
19	Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study Annals of Oncology ·David J. Stewart, Elizabeth A. Eisenhauer, Jamey Skillings, Kathleen I. Pritchard, Robert Buckman, Ted Vandenberg, Savita Verma, Allyson Thomas Oliveira de Sena, B. Norris	1992	7
20	A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin Cancer ·Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand, Allan J. Schutt, James E. Krook, John Foley, B. Norris, Carl G. Kardinal, Loren K. Tschetter, John F. Barlow	1990	171

About B. Norris

B. Norris is a scholar working on Cancer Research, Oncology, Dermatology, Genetics and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (3 papers), BRCA gene mutations in cancer (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Estrogen and related hormone effects (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.6k citations), Pathology and Forensic Medicine (227 citations), Pulmonary and Respiratory Medicine (390 citations) and Genetics (302 citations). B. Norris has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Karen A. Gelmon, Stephen Chia, Caroline Speers, Ivo A. Olivotto, Chris Bajdik, Ted Vandenberg, Kathleen I. Pritchard, Peter M. Ravdin, Greg Davis and Andrew J. Coldman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Cancer Biology & Therapy and Clinical Breast Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact